Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients
Journal of Cancer Research & Clinical Oncology, 10/01/09
Harting MT et al. – Age at diagnosis does not appear to be a significant independent prognostic variable for overall survival or disease-free survival in patients with osteosarcoma. Although our data indicate that patients in the fifth decade and older fare worse than younger patients, other variables such as tumor necrosis, tumor extension, and tumor location are likely responsible for the observed decline in overall survival and disease-free survival
Methods- 438 patients
- All ages
- Diagnosed with osteosarcoma between 1 January 1980 and 31 December 2000
- Underwent the majority of their treatment at M.D. Anderson Cancer Center (MDACC)
- Patient and tumor specific variables collected including patient demographics, patient history, primary tumor information, treatment strategy , metastatic disease information, long-term follow-up, and eventual outcome
- Statistical analyses, including univariate and multivariate analyses performed, with overall survival and disease-free survival as primary outcome measures
- Median age at diagnosis was 18.1 years (range 2 months to 78.8 years)
- Median follow-up 4.2 years (range 5 days to 22.8 years) for all patients and 12.3 years (range 1 month to 22.8 years) for 209 surviving patients
- Survival rates at 5, 10, and 15 years were 54.1, 47.2, and 45.2%, respectively
- On univariate analyses, age ≥ 40 was found to be a poor prognostic factor
- Other prognostic factors included tumor size, metastasis at diagnosis, soft-tissue tumor extension, surgery type, chemotherapy group, and tumor necrosis
- Age not identified a statistically significant prognostic variable on multivariate analysis
Today in Soft Tissue/Sarcoma...keeping you current
Receive free subspecialty "5-minute updates" via email
S-MED: Sarcoma microRNA Expression Database
Laboratory Investigation, 03/19/10
Protection from Rapamycin-Induced Apoptosis by Insulin-Like Growth Factor-I Is Partially Dependent on Protein Kinase C Signaling
Cancer Research, 03/19/10
Metronomic chemotherapy in advanced soft tissue sarcomas
Cancer Chemotherapy and Pharmacology, 03/18/10
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cryoimmunologic Antitumor Effects Enhanced by Dendritic Cells in Osteosarcoma
Clinical Orthopedics and Related Research, 03/19/10
Update and review of the management of bone tumours
Paediatrics and Child Health, 03/17/10
The Use of Indocyanine Green Videography for Intraoperative Localization of Intradural Spinal Tumors
Spine, 03/17/10
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


